Half-Life Extension of Biopharmaceuticals using Chemical Methods: Alternatives to PEGylation.
about
New Insights in the Design of Bioactive Peptides and Chelating Agents for Imaging and Therapy in Oncology.Acylated heptapeptide binds albumin with high affinity and application as tag furnishes long-acting peptides.A Peptide-Fc Opsonin with Pan-Amyloid ReactivityA brain-targeting lipidated peptide for neutralizing RNA-mediated toxicity in Polyglutamine Diseases.Recent Advances in GLP-1 Receptor Agonists for Use in Diabetes Mellitus.Xenopus-derived glucagon-like peptide-1 and polyethylene-glycosylated glucagon-like peptide-1 receptor agonists: long-acting hypoglycaemic and insulinotropic activities with potential therapeutic utilities.Improving long-term subcutaneous drug delivery by regulating material-bioenvironment interaction.Construction, Purification, and Characterization of a Homodimeric Granulocyte Colony-Stimulating Factor.Selective N-terminal acylation of peptides and proteins with a Gly-His tag sequence
P2860
Q40098290-AC25CA69-88F1-4B17-9A0F-5C4093B769E2Q41077825-262F3C7B-BDC2-4D43-9B88-E9FB95C6BD2BQ41471564-2F6BFE1B-21EF-430E-8F31-C6456E94F467Q42121340-7381FE1C-8650-4F86-A79F-E0CC6CBC477CQ47980008-63CBF38F-1E63-4A6B-B9A8-235D339BB964Q48243435-1E7873C8-7FE2-489D-AC24-8EA2DA565EFCQ49391770-ABE31809-8B49-438F-99B0-251EECE2749CQ50882900-1E97E8F7-4C05-4BC4-97C4-4DE546BD9EC9Q58770826-A2EEEDB5-D232-4434-93E1-8A8535DD34E3
P2860
Half-Life Extension of Biopharmaceuticals using Chemical Methods: Alternatives to PEGylation.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Half-Life Extension of Biophar ...... s: Alternatives to PEGylation.
@en
type
label
Half-Life Extension of Biophar ...... s: Alternatives to PEGylation.
@en
prefLabel
Half-Life Extension of Biophar ...... s: Alternatives to PEGylation.
@en
P2860
P356
P1433
P1476
Half-Life Extension of Biophar ...... ds: Alternatives to PEGylation
@en
P2093
Søren B van Witteloostuijn
Søren L Pedersen
P2860
P304
P356
10.1002/CMDC.201600374
P577
2016-10-24T00:00:00Z